CSN Login
Members Online: 5

You are here

New Clinical trial to see of Cabo will trump Sutent. This is great.

sblairc's picture
sblairc
Posts: 586
Joined: Feb 2014

Cabozanitinub is going to start studies to see if it will become a FIRST IN LINE drug for kidney cancer. 

This means that there could be a drug to come out ahead of the one already prescribed first, Sutent. 

I think the article says a Phase 3 trial is going to start of the drug.

http://www.fool.com/investing/2016/05/27/this-new-data-could-push-exelixis-cabometyx-over-1.aspx

 

This means we are getting another drug that will likely prolong survival. 

Yeric
Posts: 65
Joined: May 2015

I don't remember what drug I was getting that I was told  " There is'nt anything after this."  I do remember that it wasn't that long ago.  And here we are with new stuff to try faster than I can burn through what I am taking.  So, how many shares of drug company do I need to break even with treatment from said company??  Thanks for the link sblairc!!

Bobby

Subscribe to Comments for "New Clinical trial to see of Cabo will trump Sutent. This is great. "